Dual Use Research in the Biomedical Sciences

[1]  A. Casadevall,et al.  Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic , 2020, mBio.

[2]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[3]  Janet Zandy.  Universal Declaration of Human Rights , 2019, Radical Teacher.

[4]  Michael J. Selgelid,et al.  Gain-of-Function Research: Ethical Analysis , 2016, Science and Engineering Ethics.

[5]  R. Shaw.  Export controls and the life sciences: controversy or opportunity? , 2016, EMBO reports.

[6]  G. Ackerman,et al.  Assessing the bioweapons threat , 2015, Science.

[7]  R. Fouchier.  Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited , 2015, mBio.

[8]  R. Webster,et al.  Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness , 2014, mBio.

[9]  Marc Lipsitch,et al.  Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens , 2014, PLoS medicine.

[10]  D. Relman.  "Inconvenient truths" in the pursuit of scientific knowledge and public health. , 2014, The Journal of infectious diseases.

[11]  Gary Xie,et al.  Molecular characterization of a novel botulinum neurotoxin type H gene. , 2014, The Journal of infectious diseases.

[12]  Arturo Casadevall,et al.  Redaction of Sensitive Data in the Publication of Dual Use Research of Concern , 2013, mBio.

[13]  D. Resnik.  H5N1 avian flu research and the ethics of knowledge. , 2013, The Hastings Center report.

[14]  Marc Lipsitch,et al.  Rethinking Biosafety in Research on Potential Pandemic Pathogens , 2012, mBio.

[15]  A. Fauci.  Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward , 2012, mBio.

[16]  David Resnik,et al.  Biosecurity and the review and publication of dual-use research of concern. , 2012, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[17]  V. Radosavljevic,et al.  A Mathematical Model of Bioterrorist Attack Risk Assessment , 2012 .

[18]  David L Smith,et al.  The Potential for Respiratory Droplet–Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host , 2012, Science.

[19]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[20]  D. Resnik.  Ethical Issues Concerning Transgenic Animals in Biomedical Research , 2012 .

[21]  Gabriele Neumann,et al.  Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets , 2012, Nature.

[22]  D. Resnik,et al.  Dual-use review policies of biomedical research journals. , 2011, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[23]  John A. Sokolowski,et al.  Probabilistic Risk Analysis and Terrorism Risk , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[24]  David B. Resnik,et al.  Playing Politics with Science: Balancing Scientific Independence and Government Oversight , 2009 .

[25]  Seumas Miller,et al.  Ethical and Philosophical Consideration of the Dual-use Dilemma in the Biological Sciences , 2007, Sci. Eng. Ethics.

[26]  D. Resnik.  The Price of Truth: How Money Affects the Norms of Science , 2006 .

[27]  Brian Orend.  The Morality of War , 2006 .

[28]  Sammy Salama,et al.  Does Intent equal Capability? Al-Qaeda and Weapons of Mass Destruction , 2005 .

[29]  Phillip A Sharp,et al.  1918 Flu and Responsible Science , 2005, Science.

[30]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[31]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[32]  Lawrence M Wein,et al.  Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Bruce Alberts,et al.  Modeling attacks on the food supply. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Stefan Riedel,et al.  Biological Warfare and Bioterrorism: A Historical Review , 2004, Proceedings.

[35]  Edward H. Kaplan,et al.  Estimating Time and Size of Bioterror Attack , 2004, Emerging infectious diseases.

[36]  F. Frischknecht.  The history of biological warfare , 2003 .

[37]  G. F. Webb,et al.  A silent bomb: The risk of anthrax as a weapon of mass destruction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  David B. Resnik,et al.  Responsible Conduct of Research , 2002 .

[39]  A. Paul,et al.  Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template , 2002, Science.

[40]  Zhiping Nie,et al.  Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Runge,et al.  Smallpox and the Native American , 2002, The American journal of the medical sciences.

[42]  A. Ramsay,et al.  Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox , 2001, Journal of Virology.

[43]  Philip K. Russell,et al.  Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.

[44]  J. Robertson.  The scientist's right to research: a constitutional analysis. , 1978, Southern California law review.

[45]  D. Resnik.  Playing politics with science , 2009 .

[46]  D. Resnik.  The Price of Truth , 2007 .

[47]  P. Kitcher.  Science, Truth, and Democracy , 2001 .